Goebel, S.; Hobohm, L.; Desuki, A. et al.
Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failure in GermanyEUROPEAN HEART JOURNAL. Bd. 42. 2021 S. 1019-1019
Vonwirth, Verena; Buelbuel, Yagmur; Werner, Anke et al.
Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil GranulocytesFRONTIERS IN IMMUNOLOGY. Bd. 11. 2021
Wachholz, Vanessa; Mustafa, Al-Hassan M.; Zeyn, Yanira et al.
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3ARCHIVES OF TOXICOLOGY. Bd. 96. H. 1. 2021 S. 177-193
Leypoldt, Lisa B.; Besemer, Britta; Asemissen, Anne Marie et al.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trialLEUKEMIA. Bd. 36. H. 3. 2021 S. 885-888
Bachmann, Friederike; Schreder, Martin; Engelhardt, Monika et al.
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMMCANCERS. Bd. 13. H. 6. 2021
Sebastian, Martin; Eberhardt, Wilfried E. E.; Hoffknecht, Petra et al.
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)LUNG CANCER. Bd. 154. 2021 S. 51-61
Baertsch, Marc-Andrea; Mai, Elias K.; Hielscher, Thomas et al.
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myelomaBLOOD CANCER JOURNAL. Bd. 11. H. 1. 2021
Herold, Stephanie; Klodt, Tristan; Toelle, Daniela et al.
Lethal systemic and brain infection caused by Prototheca zopfii algae in a patient with acute myeloid leukemiaMEDICAL MYCOLOGY CASE REPORTS. Bd. 32. 2021 S. 17-20
Mueller-Calleja, Nadine; Hollerbach, Anne; Royce, Jennifer et al.
Lipid presentation by the protein C receptor links coagulation with autoimmunitySCIENCE. Bd. 371. H. 6534. 2021 S. 1121-+
Salwender, Hans; Elmaagacli, Ahmet; Merz, Maximilian et al.
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III TrialLEUKEMIA. Bd. 35. H. 10. 2021 S. 3007-3011